Amna Nawaz
@PBSNewsHour·5.3M subscribers·62.2K videos
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’
Posted
December 9, 2023
Views
10,401
Likes
195
Engagement
1.87%
December 9, 2023
10,401
195
1.87%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
5:09Now PlayingSickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Stream your PBS favorites with the PBS app
Find more from PBS NewsHour at
Subscribe to our YouTube channel
Subscribe:
PBS NewsHour podcasts
Newsletters
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
